QRICH2
gene geneOn this page
Also known as DKFZP434P0316
Summary
QRICH2 (glutamine rich 2, HGNC:25326) is a protein-coding gene on chromosome 17q25.1, encoding Glutamine-rich protein 2 (Q9H0J4). Has an essential role in the formation of sperm flagella and flagellar structure maintainance.
Involved in cell projection assembly; flagellated sperm motility; and negative regulation of ubiquitin-dependent protein catabolic process. Located in sperm flagellum. Implicated in spermatogenic failure 35.
Source: NCBI Gene 84074 — RefSeq curated summary.
At a glance
- Gene–disease (curated): spermatogenic failure 35 (Strong, GenCC)
- GWAS associations: 10
- Clinical variants (ClinVar): 373 total — 5 pathogenic, 6 likely-pathogenic
- Phenotypes (HPO): 7
- MANE Select transcript:
NM_001388453
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25326 |
| Approved symbol | QRICH2 |
| Name | glutamine rich 2 |
| Location | 17q25.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZP434P0316 |
| Ensembl gene | ENSG00000129646 |
| Ensembl biotype | protein_coding |
| OMIM | 618304 |
| Entrez | 84074 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 5 protein_coding, 1 nonsense_mediated_decay
ENST00000262765, ENST00000447564, ENST00000524722, ENST00000532549, ENST00000636395, ENST00000680821
RefSeq mRNA: 2 — MANE Select: NM_001388453
NM_001388453, NM_032134
CCDS: CCDS32741, CCDS92399
Canonical transcript exons
ENST00000680821 — 19 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001658265 | 76291015 | 76294021 |
| ENSE00001766655 | 76304882 | 76304941 |
| ENSE00001796388 | 76304415 | 76304525 |
| ENSE00003504451 | 76275819 | 76275947 |
| ENSE00003505150 | 76280654 | 76280728 |
| ENSE00003515916 | 76279363 | 76279428 |
| ENSE00003527841 | 76289992 | 76290077 |
| ENSE00003532229 | 76287800 | 76287897 |
| ENSE00003554042 | 76277163 | 76277310 |
| ENSE00003562559 | 76287192 | 76287306 |
| ENSE00003601823 | 76280831 | 76280953 |
| ENSE00003603710 | 76280033 | 76280154 |
| ENSE00003607764 | 76280287 | 76280451 |
| ENSE00003615220 | 76281864 | 76282115 |
| ENSE00003632641 | 76277989 | 76278189 |
| ENSE00003676811 | 76276680 | 76276767 |
| ENSE00003688021 | 76279041 | 76279142 |
| ENSE00003913899 | 76274049 | 76274260 |
| ENSE00003916101 | 76307465 | 76308276 |
Expression profiles
Bgee: expression breadth ubiquitous, 162 present calls, max score 88.11.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0110 / max 13.5325, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 168199 | 0.0110 | 3 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 88.11 | gold quality |
| right testis | UBERON:0004534 | 87.60 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 85.40 | gold quality |
| testis | UBERON:0000473 | 84.73 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 80.79 | gold quality |
| ventricular zone | UBERON:0003053 | 79.61 | gold quality |
| stromal cell of endometrium | CL:0002255 | 79.55 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 79.55 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 79.48 | gold quality |
| cerebellar cortex | UBERON:0002129 | 79.45 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 78.74 | gold quality |
| sural nerve | UBERON:0015488 | 78.55 | gold quality |
| cortical plate | UBERON:0005343 | 78.43 | gold quality |
| cerebellum | UBERON:0002037 | 78.02 | gold quality |
| thyroid gland | UBERON:0002046 | 77.30 | gold quality |
| ganglionic eminence | UBERON:0004023 | 77.07 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.25 | gold quality |
| right frontal lobe | UBERON:0002810 | 76.23 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 75.57 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 75.42 | gold quality |
| hypothalamus | UBERON:0001898 | 74.87 | gold quality |
| putamen | UBERON:0001874 | 74.57 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 74.43 | gold quality |
| nucleus accumbens | UBERON:0001882 | 74.10 | gold quality |
| caudate nucleus | UBERON:0001873 | 73.83 | gold quality |
| minor salivary gland | UBERON:0001830 | 73.64 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 73.17 | gold quality |
| right lobe of liver | UBERON:0001114 | 72.95 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 72.67 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.40 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.75 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
5 targeting QRICH2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3140-5P | 99.39 | 69.04 | 1136 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
| HSA-MIR-8085 | 99.28 | 67.56 | 2362 |
| HSA-MIR-660-3P | 98.14 | 66.04 | 1434 |
| HSA-MIR-572 | 85.62 | 59.34 | 30 |
Literature-anchored findings (GeneRIF, showing 3)
- The findings strongly suggest that the genetic mutations of QRICH2 can lead to male infertility with multiple morphological abnormalities of the flagella, and that QRICH2 is essential for sperm flagellar formation. (PMID:30683861)
- Whole exome sequencing of men with multiple morphological abnormalities of the sperm flagella reveals novel homozygous QRICH2 mutations. (PMID:31292949)
- Loss-of-function missense variant of AKAP4 induced male infertility through reduced interaction with QRICH2 during sperm flagella development. (PMID:34415320)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Qrich2 | ENSMUSG00000070331 |
| rattus_norvegicus | Qrich2 | ENSRNOG00000025254 |
Paralogs (4): ZP2 (ENSG00000103310), ZP4 (ENSG00000116996), ZP1 (ENSG00000149506), C16orf96 (ENSG00000205832)
Protein
Protein identifiers
Glutamine-rich protein 2 — Q9H0J4 (reviewed: Q9H0J4)
All UniProt accessions (6): Q9H0J4, A0A1B0GW36, A0A7P0T7G7, E9PPH7, H0YDB9, H7C0E3
UniProt curated annotations — full annotation on UniProt →
Function. Has an essential role in the formation of sperm flagella and flagellar structure maintainance. It acts as a suppressor of ubiquitination and degradation of proteins involved in flagellar development and motility.
Subunit / interactions. Interacts with AKAP3, ODF2 and TSSK4. Interacts with AKAP4. Interacts with CFAP70.
Subcellular location. Nucleus membrane. Nucleus. Cytoplasm. Cell projection. Cilium. Flagellum.
Tissue specificity. Expressed in the sperm.
Disease relevance. Spermatogenic failure 35 (SPGF35) [MIM:618341] An autosomal recessive infertility disorder caused by spermatogenesis defects that result in multiple abnormalities of sperm flagellum and severely impaired spermatozoa motility. The disease is caused by variants affecting the gene represented in this entry.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H0J4-1 | 1 | yes |
| Q9H0J4-2 | 2 | |
| Q9H0J4-3 | 3 |
RefSeq proteins (2): NP_001375382, NP_115510 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032013 | DUF4795 | Domain |
Pfam: PF16043
UniProt features (37 total): sequence variant 17, compositionally biased region 8, region of interest 6, splice variant 3, coiled-coil region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H0J4-F1 | 45.38 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 55 (showing top):
GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_REGULATION_OF_CATABOLIC_PROCESS, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS, GOBP_CELL_PROJECTION_ORGANIZATION, GOBP_REGULATION_OF_PROTEOLYSIS, GOBP_PROTEIN_CATABOLIC_PROCESS, GOBP_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS, GOCC_NUCLEAR_ENVELOPE, GOCC_MOTILE_CILIUM, GOBP_PROTEOLYSIS, GOCC_NUCLEAR_MEMBRANE, GOCC_CILIUM
GO Biological Process (3): cell projection assembly (GO:0030031), flagellated sperm motility (GO:0030317), negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): cytoplasm (GO:0005737), nuclear membrane (GO:0031965), sperm flagellum (GO:0036126), nucleus (GO:0005634), cilium (GO:0005929), membrane (GO:0016020), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cellular component assembly | 1 |
| cell projection organization | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| ubiquitin-dependent protein catabolic process | 1 |
| negative regulation of protein catabolic process | 1 |
| regulation of ubiquitin-dependent protein catabolic process | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| nucleus | 1 |
| nuclear envelope | 1 |
| organelle membrane | 1 |
| 9+2 motile cilium | 1 |
| intracellular membrane-bounded organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
1149 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| QRICH2 | CFAP44 | Q96MT7 | 795 |
| QRICH2 | CFAP43 | Q8NDM7 | 794 |
| QRICH2 | QRICH1 | Q2TAL8 | 734 |
| QRICH2 | CFAP69 | A5D8W1 | 706 |
| QRICH2 | ARMC2 | Q8NEN0 | 687 |
| QRICH2 | DNAH1 | Q9P2D7 | 686 |
| QRICH2 | TTC21A | Q8NDW8 | 670 |
| QRICH2 | CFAP251 | Q8TBY9 | 640 |
| QRICH2 | TTC29 | Q8NA56 | 636 |
| QRICH2 | CFAP70 | Q5T0N1 | 616 |
| QRICH2 | FSIP2 | Q5CZC0 | 600 |
| QRICH2 | CCDC39 | Q9UFE4 | 596 |
| QRICH2 | DNAH17 | Q9UFH2 | 591 |
| QRICH2 | SPEF2 | Q9C093 | 583 |
| QRICH2 | CFAP58 | Q5T655 | 581 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KMT2B | MEN1 | psi-mi:“MI:0914”(association) | 0.460 |
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
| MPDU1 | QRICH2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NUP98 | QRICH2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PANK2 | QRICH2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| EIPR1 | QRICH2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| QRICH2 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| MAGEB2 | QRICH2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNRD2 | QRICH2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GAPDH | QRICH2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SNAI1 | QRICH2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DISC1 | QRICH2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (9): QRICH2 (Affinity Capture-MS), QRICH2 (Affinity Capture-MS), QRICH2 (Affinity Capture-MS), QRICH2 (Affinity Capture-MS), QRICH2 (Affinity Capture-MS), QRICH2 (Affinity Capture-MS), QRICH2 (Affinity Capture-MS), QRICH2 (Affinity Capture-RNA), QRICH2 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GUY1, A6NJ88, A6QL64, B3KS81, E9Q6E9, O43493, O48582, O77733, P04279, P0C7A4, P0C7A5, P0CV57, P0DKJ7, P10322, P16225, P48997, P48998, Q02383, Q06990, Q08AG5, Q0ZNK1, Q5JPF3, Q5JRC9, Q5SRN2, Q5U7M7, Q5U7M8, Q5U7M9, Q5U7N0, Q5U7N1, Q5U7N3, Q5U7N4, Q5XHX6, Q659K0, Q6AYN3, Q6JHY2, Q6P902, Q6SJ82, Q6X2M3, Q6XPR3, Q80Y39
Diamond homologs: A6NNT2, E9QMW4, Q3V2A7, Q9H0J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
373 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 5 |
| Likely pathogenic | 6 |
| Uncertain significance | 231 |
| Likely benign | 59 |
| Benign | 41 |
Top pathogenic / likely-pathogenic (11)
| Variant ID | HGVS | Classification |
|---|---|---|
| 619117 | NM_001388453.1(QRICH2):c.690G>A (p.Trp230Ter) | Pathogenic |
| 619118 | NM_001388453.1(QRICH2):c.3535C>T (p.Arg1179Ter) | Pathogenic |
| 815953 | GRCh37/hg19 17q25.1-25.3(chr17:73261871-78608763)x3 | Pathogenic |
| 974676 | NM_001388453.1(QRICH2):c.3999C>G (p.Tyr1333Ter) | Pathogenic |
| 974677 | NM_001388453.1(QRICH2):c.5112C>G (p.Tyr1704Ter) | Pathogenic |
| 1298725 | NM_001388453.1(QRICH2):c.5266-2A>G | Likely pathogenic |
| 2630353 | NM_001388453.1(QRICH2):c.4914dup (p.Asn1639fs) | Likely pathogenic |
| 3356262 | NM_001388453.1(QRICH2):c.5482+1G>A | Likely pathogenic |
| 3780515 | NM_001388453.1(QRICH2):c.5171dup (p.Ser1725fs) | Likely pathogenic |
| 3892239 | NM_001388453.1(QRICH2):c.1507C>T (p.Gln503Ter) | Likely pathogenic |
| 3892240 | NM_001388453.1(QRICH2):c.3952_3953del (p.Arg1318fs) | Likely pathogenic |
SpliceAI
3381 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:76275948:CT:C | acceptor_loss | 1.0000 |
| 17:76276678:A:AC | donor_gain | 1.0000 |
| 17:76276678:ACTGT:A | donor_gain | 1.0000 |
| 17:76276679:C:CC | donor_gain | 1.0000 |
| 17:76276679:CT:C | donor_gain | 1.0000 |
| 17:76276679:CTGT:C | donor_gain | 1.0000 |
| 17:76276679:CTGTC:C | donor_gain | 1.0000 |
| 17:76276764:CATG:C | acceptor_gain | 1.0000 |
| 17:76276766:TG:T | acceptor_gain | 1.0000 |
| 17:76276768:C:CC | acceptor_gain | 1.0000 |
| 17:76277309:CC:C | acceptor_gain | 1.0000 |
| 17:76277310:CC:C | acceptor_gain | 1.0000 |
| 17:76277311:C:CC | acceptor_gain | 1.0000 |
| 17:76278041:T:C | donor_gain | 1.0000 |
| 17:76278197:G:C | acceptor_gain | 1.0000 |
| 17:76278197:G:GC | acceptor_gain | 1.0000 |
| 17:76279039:A:AC | donor_gain | 1.0000 |
| 17:76279040:C:CC | donor_gain | 1.0000 |
| 17:76279141:CA:C | acceptor_gain | 1.0000 |
| 17:76279143:C:CC | acceptor_gain | 1.0000 |
| 17:76279361:A:AC | donor_gain | 1.0000 |
| 17:76279362:C:CC | donor_gain | 1.0000 |
| 17:76280028:CTCA:C | donor_loss | 1.0000 |
| 17:76280029:TCA:T | donor_loss | 1.0000 |
| 17:76280030:CA:C | donor_loss | 1.0000 |
| 17:76280031:A:AC | donor_gain | 1.0000 |
| 17:76280031:A:AT | donor_loss | 1.0000 |
| 17:76280031:ACCT:A | donor_gain | 1.0000 |
| 17:76280032:C:CC | donor_gain | 1.0000 |
| 17:76280032:CCT:C | donor_gain | 1.0000 |
AlphaMissense
12279 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:76279406:A:G | C1425R | 0.998 |
| 17:76279404:G:C | C1425W | 0.997 |
| 17:76279396:C:T | C1428Y | 0.996 |
| 17:76279405:C:G | C1425S | 0.995 |
| 17:76279405:C:T | C1425Y | 0.995 |
| 17:76279406:A:T | C1425S | 0.995 |
| 17:76279410:G:C | F1423L | 0.995 |
| 17:76279410:G:T | F1423L | 0.995 |
| 17:76279412:A:G | F1423L | 0.995 |
| 17:76281928:A:G | L1234P | 0.995 |
| 17:76280384:A:G | L1344P | 0.994 |
| 17:76280889:A:G | L1277P | 0.994 |
| 17:76282105:A:G | L1175P | 0.994 |
| 17:76279396:C:G | C1428S | 0.993 |
| 17:76279397:A:G | C1428R | 0.993 |
| 17:76279397:A:T | C1428S | 0.993 |
| 17:76280868:A:G | L1284P | 0.993 |
| 17:76279395:A:C | C1428W | 0.992 |
| 17:76279396:C:A | C1428F | 0.991 |
| 17:76280363:A:G | L1351P | 0.991 |
| 17:76279405:C:A | C1425F | 0.990 |
| 17:76287277:A:G | L1143P | 0.990 |
| 17:76279390:C:G | R1430P | 0.989 |
| 17:76279411:A:G | F1423S | 0.989 |
| 17:76280106:A:G | W1393R | 0.989 |
| 17:76280106:A:T | W1393R | 0.989 |
| 17:76304447:C:G | A59P | 0.989 |
| 17:76276728:A:C | Y1603D | 0.988 |
| 17:76287202:A:G | L1168P | 0.988 |
| 17:76304455:A:G | L56P | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000058997 (17:76306931 G>A), RS1000266899 (17:76311518 C>G), RS1000272203 (17:76310421 C>T), RS1000334016 (17:76277858 TTCTC>T,TTC,TTCTCTC), RS1000401798 (17:76282925 T>G), RS1000508785 (17:76305042 C>A,T), RS1000554076 (17:76308953 G>T), RS1000558377 (17:76276875 G>A), RS1000607739 (17:76308768 G>C), RS1000658046 (17:76289926 G>T), RS1000687718 (17:76289632 A>G), RS1000791018 (17:76286957 G>A,T), RS1000941874 (17:76281273 G>A), RS1001142229 (17:76281562 G>A), RS1001200875 (17:76296437 G>C)
Disease associations
OMIM: gene MIM:618304 | disease phenotypes: MIM:618341
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| spermatogenic failure 35 | Strong | Autosomal recessive |
Mondo (1): spermatogenic failure 35 (MONDO:0032686)
Orphanet (0):
HPO phenotypes
7 total (7 of 7 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0003251 | Male infertility |
| HP:0011462 | Young adult onset |
| HP:0032558 | Absent sperm flagella |
| HP:0032559 | Short sperm flagella |
| HP:0032560 | Coiled sperm flagella |
| HP:0033525 | Absent sperm axoneme central pair complex |
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001791_20 | Urate levels | 2.000000e-07 |
| GCST003245_5 | White matter hyperintensities in ischemic stroke | 1.000000e-06 |
| GCST007733_21 | Serum uric acid levels | 2.000000e-07 |
| GCST008971_116 | Urate levels | 6.000000e-08 |
| GCST008972_22 | Urate levels | 1.000000e-10 |
| GCST010173_86 | Triglyceride levels | 2.000000e-10 |
| GCST010244_153 | Triglyceride levels | 1.000000e-11 |
| GCST010637_26 | Urate levels | 4.000000e-08 |
| GCST90020025_1462 | Waist-to-hip ratio adjusted for BMI | 1.000000e-10 |
| GCST90020027_587 | Waist-hip index | 2.000000e-10 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004531 | urate measurement |
| EFO:0005665 | white matter hyperintensity measurement |
| EFO:0004761 | uric acid measurement |
| EFO:0004530 | triglyceride measurement |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| 2,5,2’,5’-tetrachlorobiphenyl | decreases expression | 1 |
| sulforaphane | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| benzo(e)pyrene | affects methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| bisphenol S | decreases expression | 1 |
| jinfukang | decreases expression, affects cotreatment | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Methapyrilene | affects methylation | 1 |
| Quercetin | increases expression | 1 |
| Rotenone | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: spermatogenic failure 35
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): spermatogenic failure 35